Cargando…

Purine Inhibitors of Cyclin-Dependent Kinase and Their Apoptosis and Cytotoxicity Mechanisms

Detalles Bibliográficos
Autores principales:	Strnad, M., Havlíček, L., Kryštof, P. V., Lenobel, R., Hanuš, J., Siglerová, V., Hajdúch, L. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2001
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084685/ https://www.ncbi.nlm.nih.gov/pubmed/30147527 http://dx.doi.org/10.1100/tsw.2001.228

Ejemplares similares

Cyclin-Dependent Kinase Inhibitors Induce Apoptosis in Plant Cells
por: Strnad, M., et al.
Publicado: (2001)

Olomoucine II, New Effective CDK Inhibitor with Strong Cytotoxic Properties
por: Lenobel, R., et al.
Publicado: (2001)

Cyclin-Dependent Kinase 9 Activity Regulates Neutrophil Spontaneous Apoptosis
por: Wang, Keqing, et al.
Publicado: (2012)

Initiation of apoptosis by photodynamic therapy on MCF7 cells
por: Kolacaronova, Hana, et al.
Publicado: (2001)

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
por: Kryštof, Vladimír, et al.
Publicado: (2012)

Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2020)

Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs
por: Cartwright, Jennifer A., et al.
Publicado: (2019)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationship of Substituted Quinazolinones as Cyclin-Dependent Kinase 9 Inhibitors
por: Alkahtani, Hamad M., et al.
Publicado: (2022)

Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
por: Weitensteiner, Sabine B., et al.
Publicado: (2013)

Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor
por: Fu, W, et al.
Publicado: (2013)

Cyclin-dependent kinase 2 protects podocytes from apoptosis
por: Saurus, Pauliina, et al.
Publicado: (2016)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

The Cyclin-dependent Kinase Cdk2 Regulates Thymocyte Apoptosis
por: Hakem, Anne, et al.
Publicado: (1999)

Efficient Activation of Reconstructed Rat Embryos by Cyclin-Dependent Kinase Inhibitors
por: Webb, Robin L., et al.
Publicado: (2010)

Induction of Eosinophil Apoptosis by the Cyclin-Dependent Kinase Inhibitor AT7519 Promotes the Resolution of Eosinophil-Dominant Allergic Inflammation
por: Alessandri, Ana L., et al.
Publicado: (2011)

Purine analogs as phosphatidylinositol 4-kinase IIIβ inhibitors
por: Šála, Michal, et al.
Publicado: (2016)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action
por: Łukasik, Paweł, et al.
Publicado: (2021)

Total synthesis of [(15)N]-labelled C6-substituted purines from [(15)N]-formamide—easy preparation of isotopically labelled cytokinins and derivatives
por: Buček, Jan, et al.
Publicado: (2018)

Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy
por: Ullah, Zakir, et al.
Publicado: (2009)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

The cyclin-dependent kinase inhibitor AT7519 accelerates neutrophil apoptosis in sepsis-related acute respiratory distress syndrome
por: Dorward, David A, et al.
Publicado: (2017)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Optimization of Luminescent Assay for Screening of Cyclin-Dependent Kinase 2 Inhibitors
por: Suthar, M. P., et al.
Publicado: (2010)

Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin-dependent kinase inhibitors
por: Kubczak, Małgorzata, et al.
Publicado: (2019)

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy: Miniperspective
por: Sonawane, Yogesh A., et al.
Publicado: (2016)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
por: Tavakolian, Shaian, et al.
Publicado: (2020)

Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma
por: Noonan, Janis J., et al.
Publicado: (2019)

Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance
por: Kaliszczak, M, et al.
Publicado: (2013)

Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity
por: Rouchal, Michal, et al.
Publicado: (2021)

Purine-Metabolising Enzymes and Apoptosis in Cancer
por: Camici, Marcella, et al.
Publicado: (2019)

Alsterpaullone, a Cyclin-Dependent Kinase Inhibitor, Mediated Toxicity in HeLa Cells through Apoptosis-Inducing Effect
por: Cui, Chunying, et al.
Publicado: (2013)

Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice
por: Sallam, Hatem, et al.
Publicado: (2013)

The inhibitors of cyclin-dependent kinases and GSK-3β enhance osteoclastogenesis
por: Akiba, Yosuke, et al.
Publicado: (2015)

Are all cyclin-dependent kinases 4/6 inhibitors created equal?
por: Marra, Antonio, et al.
Publicado: (2019)

The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer
por: Tanaka, Tomohito, et al.
Publicado: (2017)

Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy
por: Li, Bin-Bin, et al.
Publicado: (2019)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
por: Alsfouk, Aisha
Publicado: (2021)

Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
por: Thoma, Oana-Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k6kpumvtpm4ujfpjniao6vogg0